Is the inflammasome a potential therapeutic target in renal disease?
about
The Nucleotide Oligomerization Domain-Like Receptors in Kidney InjuryROS-Mediated NLRP3 Inflammasome Activation in Brain, Heart, Kidney, and Testis Ischemia/Reperfusion InjurySecondary amyloidosis in autoinflammatory diseases and the role of inflammation in renal damageNephropathy in dietary hyperoxaluria: A potentially preventable acute or chronic kidney diseaseTargeting HO-1 by Epigallocatechin-3-Gallate Reduces Contrast-Induced Renal Injury via Anti-Oxidative Stress and Anti-Inflammation Pathways.NLRP3 Inflammasome Polymorphism and Macrovascular Complications in Type 2 Diabetes PatientsRenal systems biology of patients with systemic inflammatory response syndromeCharacterization and Activation of NLRP3 Inflammasomes in the Renal Medulla in Mice.Transcriptome analysis reveals manifold mechanisms of cyst development in ADPKD.Influence of the Expression of Inflammatory Markers on Kidney after Fetal Programming in an Experimental Model of Renal Failure.Renal P2 receptors and hypertension.Inflammasome Activation in Chronic Glomerular Diseases.Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRID3) in Murine Models of Dermal and Pulmonary Inflammation.Anti-inflammatory effects of triptolide on IgA nephropathy in rats.Pioglitazone ameliorates glomerular NLRP3 inflammasome activation in apolipoprotein E knockout mice with diabetes mellitus.Mitochondria Protection after Acute Ischemia Prevents Prolonged Upregulation of IL-1β and IL-18 and Arrests CKD.Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice.The regulation of NLRP3 inflammasome expression during the development of cardiac contractile dysfunction in chronic kidney disease.The study on the material basis and the mechanism for anti-renal interstitial fibrosis efficacy of rhubarb through integration of metabonomics and network pharmacology.Polydatin attenuates potassium oxonate-induced hyperuricemia and kidney inflammation by inhibiting NF-κB/NLRP3 inflammasome activation via the AMPK/SIRT1 pathway.Expression of TLR2, NOD1, and NOD2 and the NLRP3 Inflammasome in Renal Tubular Epithelial Cells of Male versus Female Mice.Regulation of TLR2 and NLRP3 in primary murine renal tubular epithelial cells.P2X7 receptor antagonism ameliorates renal dysfunction in a rat model of sepsis.Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome
P2860
Q26740429-8541CE63-8064-422A-9FF3-708BA08FA6D4Q26748988-2BC2AF32-05AB-48F1-AB73-D4A5F8CD9D8FQ26770744-60A8F892-8B31-4488-BA98-6D130B97667EQ26865804-9CB427F1-1DA3-452F-A6D6-53795697A300Q35920544-C6946E33-4AEC-43C4-A6E3-8480820D40B4Q35932364-62E7953D-F300-46E4-AAC2-AE2FDD154C60Q36113202-643AF0F6-A6E7-43D1-BC5A-CF6D3B277B96Q36777354-A0C4C958-26F6-4AD8-AC59-20F5483A5ED8Q37426288-515D07B2-543B-4F17-8EC8-BE3E7C6041DDQ37492648-D9A8DBA3-F347-4C14-AB38-BF78F1D7721BQ38262806-C3D277F8-66C5-4E80-AFC6-BEDA29FAEE3DQ38931056-D1B655CC-A970-499A-8574-70798E36BD15Q38936622-28544A30-3C1A-4E9C-BE41-B48C99DC294AQ39493410-3D1EF851-016F-4C34-ADC7-8EAD449469AEQ40432508-EE40EE88-BFB3-4FDB-9C92-3834B0E9D0A5Q41017644-E532712B-40EF-444E-A47C-E0E01A6B72CBQ46455327-2903249D-3244-4485-B711-6DDCC634E90CQ46737437-02FB8300-AC6B-4615-9E3A-DD447CC662CFQ49678863-E69DBB61-D19F-4D35-9F74-27720F500485Q51013862-35688B8C-5C00-4498-B00E-7CC3A6114CB3Q51043195-A1ACC767-B3CA-41F3-B60E-340952A820C7Q52765638-BD1AF8FE-4256-4AC6-890A-D08E94E281DCQ54211003-3A84CE1B-F66C-4C73-8E6B-2ABEF6D5EA7BQ55137356-6B9CA985-460A-46A8-A581-1428DDBA90DBQ57117487-1EC1AD08-58DE-41AB-9B53-1DE05284A310
P2860
Is the inflammasome a potential therapeutic target in renal disease?
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Is the inflammasome a potential therapeutic target in renal disease?
@en
type
label
Is the inflammasome a potential therapeutic target in renal disease?
@en
prefLabel
Is the inflammasome a potential therapeutic target in renal disease?
@en
P2093
P2860
P356
P1433
P1476
Is the inflammasome a potential therapeutic target in renal disease?
@en
P2093
Clare M Turner
Frederick W K Tam
Nishkantha Arulkumaran
Robert J Unwin
P2860
P2888
P356
10.1186/1471-2369-15-21
P577
2014-01-23T00:00:00Z
P5875
P6179
1025791606